Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FMO5 Antikörper (C-Term)

FMO5 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB42789 unconjugated
Produktnummer ABIN1881348
  • Target Alle FMO5 Antikörper anzeigen
    FMO5 (Flavin Containing Monooxygenase 5 (FMO5))
    Bindungsspezifität
    • 15
    • 13
    • 6
    • 6
    • 2
    • 1
    • 1
    • 1
    AA 474-502, C-Term
    Reaktivität
    • 41
    • 22
    • 20
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 39
    • 2
    Kaninchen
    Klonalität
    • 41
    Polyklonal
    Konjugat
    • 17
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser FMO5 Antikörper ist unkonjugiert
    Applikation
    • 39
    • 20
    • 13
    • 13
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This FMO5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-502 amino acids from the C-terminal region of human FMO5.
    Klon
    RB42789
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product FMO5 Primärantikörper
  • Applikationshinweise
    WB: 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Ross, Katzov-Eckert, Dubé, Brooks, Rassekh, Barhdadi, Feroz-Zada, Visscher, Brown, Rieder, Rogers, Phillips, Carleton, Hayden: "Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy." in: Nature genetics, Vol. 41, Issue 12, pp. 1345-9, (2009) (PubMed).

    Furnes, Feng, Sommer, Schlenk: "Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 31, Issue 2, pp. 187-93, (2003) (PubMed).

  • Target
    FMO5 (Flavin Containing Monooxygenase 5 (FMO5))
    Andere Bezeichnung
    FMO5 (FMO5 Produkte)
    Synonyme
    MGC68633 antikoerper, MGC108355 antikoerper, sb:cb1007 antikoerper, wu:fc05b01 antikoerper, wu:fk47g04 antikoerper, 5033418D19Rik antikoerper, AI195026 antikoerper, flavin containing monooxygenase 5 S homeolog antikoerper, flavin containing monooxygenase 5 antikoerper, fmo5.S antikoerper, fmo5 antikoerper, MCYG_00559 antikoerper, FMO5 antikoerper, Fmo5 antikoerper
    Hintergrund
    Metabolic N-oxidation of the diet-derived amino-trimethylamine (TMA) is mediated by flavin-containing monooxygenase and is subject to an inherited FMO3 polymorphism in man resulting in a small subpopulation with reduced TMA N-oxidation capacity resulting in fish odor syndrome Trimethylaminuria. Three forms of the enzyme, FMO1 found in fetal liver, FMO2 found in adult liver, and FMO3 are encoded by genes clustered in the 1q23-q25 region. Flavin-containing monooxygenases are NADPH-dependent flavoenzymes that catalyzes the oxidation of soft nucleophilic heteroatom centers in drugs, pesticides, and xenobiotics. Alternative splicing results in multiple transcript variants.
    Molekulargewicht
    60221
    NCBI Accession
    NP_001138301, NP_001138302, NP_001452
    UniProt
    P49326
Sie sind hier:
Kundenservice